search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


The use of tele-cardiology and bedside biomarkers in recognizing ischemic heart disease in general practice.


- candidate number8712
- NTR NumberNTR2625
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR29-nov-2010
- Secondary IDsNL 32981.099.10 METC UMCG
- Public TitleThe use of tele-cardiology and bedside biomarkers in recognizing ischemic heart disease in general practice.
- Scientific TitleThe use of tele-cardiology and bedside biomarkers in recognizing ischemic heart disease in general practice.
- ACRONYMCAVARI (cardio vascular risk)
- hypothesisWith the use of tele-cardiology and bedside biomarkers more patients with ischemic heart disease will be recognized compared to care as usual and unnecessary hospital admissions will be prevented.
- Healt Condition(s) or Problem(s) studiedIschaemic heart disease, Tele cardiology, Bedside biomarkers
- Inclusion criteriaPatients presented to the general practitioner with symptoms compatible with ischemic heart disease.
- Exclusion criteria1. Age <18 jears;
2. Shock.
- mec approval receivedyes
- multicenter trialno
- randomisedno
- groupParallel
- TypeSingle arm
- Studytypeintervention
- planned startdate 1-jan-2010
- planned closingdate1-jan-2012
- Target number of participants400
- InterventionsIn this study we apply a portable ECG device: Mortara Eli 10. It makes a 10 leads ECG wich can be send to the hospital or cariologist nearby with the use of a cellular Phone application.

Biomarkers: We use 2 bedside biomarkers: FABP (fatty acid binding proteine) and Troponine I: Cardiodetect combi test (immunoassay ). The investigator can read the result of this test 15 minutes after the application of 3 drops of blood. In addition we will use the Troponine T by taking a sample of venous blood.
- Primary outcome1. Number of patients detected by the test (tele ECG and biomarkers);
2. Number of patients not admitted to the hospital because of test results.
- Secondary outcomeMorbidity ischemic heart disease in patients admitted to the hospital after detection by the test (tele ECG and biomarkers).
- Timepoints1. 01-06-2011: End of inclusion of first 200 patients;
2. 01-12-2011: End of inclusion of second 200 patients.
- Trial web siteN/A
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIES Paul Bögels
- CONTACT for SCIENTIFIC QUERIES Paul Bögels
- Sponsor/Initiator University Medical Center Groningen (UMCG), Department of General Practice
- Funding
(Source(s) of Monetary or Material Support)
De Friesland Zorgverzekeraar
- PublicationsN/A
- Brief summaryIn this trial we examine the influence of the use of tele cardiology and bedside biomarkers (Fatty Acid Binding Proteine and Troponine I) in recognizing patients with ischemic heart disease. We aim to include 200 patients in the first part of the study. In this fase there will be contact with a cardiologist in all cases. In the second part of the study (also aim 200 patients) the general practitioner will make his/her decision only with the use of the tele ECG and biomarkers.
- Main changes (audit trail)
- RECORD29-nov-2010 - 11-dec-2010


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl